Evidence map›Paper›PMID 41196015›Full record

ArticleAging2025

Correction for: ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.

Meng Zheng, Yuchun Niu, Junguo Bu, Shumei Liang, Zhilin Zhang, Jianhua Liu, Linlang Guo, Zhihua Zhang, Qiongyao Wang

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Meng ZhengDepartment of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Yuchun NiuDepartment of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Junguo BuDepartment of Radiotherapy, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Shumei LiangDepartment of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Zhilin ZhangDepartment of Radiotherapy, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China.
Jianhua LiuDepartment of Respiratory Medicine, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China.
Linlang GuoDepartment of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Zhihua ZhangDepartment of Respiratory Medicine, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China.
Qiongyao WangDepartment of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CARM1chemoresistanceESRP1small cell lung cancerTGF-β/Smad pathway

Identifiers

PMID41196015
PMCPMC12606958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.